other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}

Adviser Profile

As of Date 03/26/2024
Adviser Type - Large advisory firm
Number of Employees 5 -16.67%
of those in investment advisory functions 5
Registration California, Terminated, 10/29/2017
Other registrations (2)
AUM* 257,631,514 -41.78%
of that, discretionary 257,631,514 -41.78%
Private Fund GAV* 257,631,514 -41.78%
Avg Account Size 64,407,879 -27.23%
SMA’s No
Private Funds 2 1
Contact Info 415 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
737M 632M 527M 421M 316M 211M 105M
2017 2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeHedge Fund Count1 GAV$170,017,144
Fund TypeOther Private Fund Count1 GAV$87,614,370

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser SILVERARC CAPITAL MANAGEMENT, LLC Hedge Fund485.2m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV485.2m AUM723.9m #Funds2
Adviser WELTON INVESTMENT PARTNERS LLC Hedge Fund440.2m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV440.2m AUM440.2m #Funds2
Adviser RIPOSTE CAPITAL LLC Hedge Fund390.1m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV390.1m AUM390.1m #Funds1
Adviser INCA INVESTMENTS, LLC Hedge Fund204.7m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV204.7m AUM486.0m #Funds1
Adviser THOMIST CAPITAL MANAGEMENT, LP Hedge Fund370.2m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV370.2m AUM445.2m #Funds1
Adviser HEDONOVA ADVISORS LLC Hedge Fund643.2m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV643.2m AUM823.8m #Funds1
Adviser CARTICA MANAGEMENT, LLC Hedge Fund1.7m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV1.7m AUM1.7m #Funds2
Adviser ACKERMAN CAPITAL MANAGEMENT Hedge Fund22.8m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV22.8m AUM445.4m #Funds2
Adviser LIONSTONE CAPITAL MANAGEMENT LLC Hedge Fund659.0m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV659.0m AUM485.2m #Funds4
Adviser TSW II CAPITAL ADVISORS, LLC Hedge Fund471.0m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV471.0m AUM430.9m #Funds7

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker78462F103 Stock NameSPDR S&P 500 ETF TR (PUT) $ Position$43,032,000 % Position33.00% $ Change # Change
Stck Ticker04280A100 Stock NameARROWHEAD PHARMACEUTICALS IN $ Position$15,414,898 % Position12.00% $ Change-35.00% # Change-12.00%
Stck Ticker09627Y109 Stock NameBLUEPRINT MEDICINES CORP $ Position$11,525,500 % Position9.00% $ Change-7.00% # Change9.00%
Stck Ticker04335A105 Stock NameARVINAS INC $ Position$9,575,307 % Position7.00% $ Change-16.00% # Change-9.00%
Stck Ticker501575104 Stock NameKYMERA THERAPEUTICS INC $ Position$9,879,806 % Position7.00% $ Change1.00% # Change-37.00%
Stck Ticker75901B107 Stock NameREGENXBIO INC $ Position$9,763,127 % Position7.00% $ Change-8.00% # Change3.00%
Stck TickerN5749R100 Stock NameMERUS N V $ Position$5,888,036 % Position4.00% $ Change-33.00% # Change-20.00%
Stck Ticker82686Q101 Stock NameSILENCE THERAPEUTICS PLC $ Position$5,766,951 % Position4.00% $ Change-39.00% # Change-37.00%
Stck Ticker007002108 Stock NameADICET BIO INC $ Position$3,644,919 % Position3.00% $ Change19.00% # Change0.00%
Stck Ticker74019P207 Stock NamePRECISION BIOSCIENCES INC $ Position$3,420,955 % Position3.00% $ Change-8.00% # Change0.00%

Brochure Summary

Overview

Aquilo is a California limited liability company that was founded in 2010. It was formed and is operated to manage investment funds and separately managed accounts for individual clients. Aquilo’s manager, controlling owner, and portfolio manager is Marc R. Schneidman. Aquilo currently manages four investment funds Aquilo Capital, L.P. (the “Core Fund”), a master fund, Aquilo Capital Offshore, Ltd. (the “Offshore Fund”), a feeder fund to the Core Fund, Aquilo Capital LO, L.P., (the “LO Fund”), a master fund, and Aquilo Capital LO Offshore, Ltd. (the “LO Offshore Fund”), a feeder fund to the LO Fund (collectively known as the “Funds”) and it only manages assets on a discretionary basis. It currently has no separate account clients, but it may accept a separate account client
in the future. Aquilo invests principally, but not solely, in equity and equity-related securities that are issued by companies in the life sciences industry and that are traded publicly in U.S. and non-U.S. markets on behalf of its clients but is authorized to enter into any type of investment transaction that it deems appropriate under the terms of the client’s partnership or other account agreement. The Funds are managed in accordance with their own investment objectives and are not tailored to any particular private fund investor. Aquilo does not participate in wrap fee programs. As of December 31, 2023, Aquilo managed regulatory assets of approximately $257.6 million on a discretionary basis. Aquilo Capital Management, LLC – ADV Part 2A Page 5